Randomized, double-blind, placebo-controlled phase I trial of pegylated megakaryocyte growth and development factor (PEG-rHuMGDF) administered to patients with advanced cancer before and after chemotherapy - Early results.
Details
Publication Year 1995-11-15, Volume 86, Issue #10, Page 1014-1014
Journal Title
BLOOD
Publication Type
Journal Article
Publisher
W B SAUNDERS CO
Rights Notice
Refer to copyright notice on published article.


Creation Date: 1995-11-15 12:00:00
Last Modified: 0001-01-01 12:00:00
An error has occurred. This application may no longer respond until reloaded. Reload 🗙